Correction to: YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma
- PDF / 201,051 Bytes
- 1 Pages / 595.276 x 790.866 pts Page_size
- 89 Downloads / 148 Views
CORRECTION
Open Access
Correction to: YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma Jiajie Hou1,2,3,4*†, He Zhang1,5†, Jun Liu6†, Zhenjun Zhao1, Jianye Wang1, Zhike Lu6, Bian Hu7, Jiankui Zhou7, Zhicong Zhao1, Mingxuan Feng1, Haiyan Zhang4,8, Bin Shen9, Xingxu Huang7, Beicheng Sun2, Mark J. Smyth8, Chuan He6,10* and Qiang Xia1* Correction to: Mol Cancer 18, 163 (2019) https://doi.org/10.1186/s12943-019-1082-3 Following the publication of the original article [1], the author list lacked a co-author’s name: Mark J. Smyth, and his affiliation is QIMR Berghofer Medical Research Institute. The correct author list should be “Jiajie Hou; He Zhang; Jun Liu; Zhenjun Zhao; Jianye Wang; Zhike Lu; Bian Hu; Jiankui Zhou; Zhicong Zhao; Mingxuan Feng; Haiyan Zhang; Bin Shen; Xingxu Huang; Beicheng Sun; Mark J. Smyth; Chuan He; Qiang Xia”. The error has been corrected in the HTML and PDF version of this article.
China. 8Immunology of Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland 4006, Australia. 9Key Laboratory of Reproductive Medicine, Department of Histology and Embryology, Nanjing Medical University, Nanjing 211166, China. 10Howard Hughes Medical Institute, University of Chicago, Chicago, IL 60637, USA.
Reference 1. Hou J, Zhang H, Liu J, et al. YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma. Mol Cancer. 2019;18: 163 https://doi.org/10.1186/s12943-019-1082-3.
Author details 1 Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200127, China. 2Department of Hepatobiliary Surgery, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing 210093, China. 3Department of Hepatobiliary Surgery, Sun Yat-sen University Cancer Center, Guangzhou 510060, China. 4State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou 510060, China. 5Department of Surgery, The University of Hong Kong-Shenzhen Hospital, Shenzhen 518053, China. 6Department of Chemistry, Department of Biochemistry and Molecular Biology, Institute for Biophysical Dynamics, University of Chicago, Chicago, IL 60637, USA. 7School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, The original article can be found online at https://doi.org/10.1186/s12943019-1082-3. * Correspondence: [email protected]; [email protected]; [email protected] † Jiajie Hou, He Zhang and Jun Liu contributed equally to this work. 1 Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200127, China 6 Department of Chemistry, Department of Biochemistry and Molecular Biology, Institute for Biophysical Dynamics, University of Chicago, Chicago, IL 60637, USA Full list of author information is available at the end of the article © The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sha
Data Loading...
